Slotnik Capital, LLC 13F: Quarter-over-Quarter Portfolio Changes
Slotnik Capital, LLC reported a disclosed portfolio value of approximately $359.4 million in its latest SEC Form 13F-HR filing for Q2 2026, up 6.8% quarter on quarter. Over the quarter, the fund initiated 14 new positions, bought more shares in 4 holdings, trimmed 5 holdings, and exited 12 positions.
Slotnik Capital, LLC's top buy was a new stake in Taylor Morrison Home CORP (TMHC) , equal to 10.7% of the disclosed portfolio. Its top sell was Masimo CORP (MASI) . The fund exited the position completely after it had accounted for 12.7% of the previous portfolio.
New PositionsQ2 2026
Securities disclosed for the first time in Q2 2026 that were not present in the prior 13F-HR filing.
| Company | Ticker | Initial Portfolio Weight | History |
|---|---|---|---|
| TAYLOR MORRISON HOME CORP | TMHC | 10.7% | History → |
| APOGEE THERAPEUTICS INC | APGE | 9.6% | History → |
| GLOBALSTAR INC | GSAT | 7.9% | History → |
| NUVALENT INC | NUVL | 7.2% | History → |
| BIO-TECHNE CORP | TECH | 4.0% | History → |
| ROKU INC | ROKU | 2.6% | Holders → |
| BROWN-FORMAN CORP CL A | BF/A | 2.5% | – |
| ARCOSA INC | ACA | 1.8% | Holders → |
| LIVERAMP HLDGS INC | RAMP | 1.6% | Holders → |
| ARRAY DIGITAL INFRASTRUCTURE | AD | 1.3% | Holders → |
| BEAZER HOMES USA INC | BZH | 1.2% | Holders → |
| SYNAPTICS INC | SYNA | 0.6% | Holders → |
| BIO RAD LABS INC | BIO | 0.6% | Holders → |
| OLAPLEX HLDGS INC | OLPX | 0.6% | Holders → |
Top BuysQ2 2026
The fund's top buys among existing positions in Q2 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.
| Company | Ticker | Portfolio Weight Change | More Shares | History |
|---|---|---|---|---|
| KENVUE INC | KVUE | +4.3% | +89.6% | History → |
| PENUMBRA INC | PEN | +1.8% | +31.7% | History → |
| ATRIUM THERAPEUTICS INC | RNA | +0.2% | +31.3% | Holders → |
| NORFOLK SOUTHN CORP | NSC | +0.3% | +17.6% | Holders → |
Top SellsQ2 2026
The fund's top sells among positions it retained in Q2 2026. Ranked by portfolio-weight impact. Full exits are listed separately.
| Company | Ticker | Portfolio Weight Change | Shares Sold | History |
|---|---|---|---|---|
| MISSION PRODUCE INC | AVO | -1.8% | 45.1% | Holders → |
| WEBSTER FINL CORP | WBS | -2.3% | 43.4% | History → |
| CHART INDS INC | GTLS | -6.1% | 41.4% | History → |
| LIBERTY BROADBAND CORP | LBRDA | -3.7% | 33.1% | Holders → |
| WARNER BROS DISCOVERY INC | WBD | -1.2% | 18.4% | History → |
Full ExitsQ2 2026
Positions present in the prior 13F-HR filing that no longer appear in Q2 2026.
| Company | Ticker | Last-Reported Portfolio Weight |
|---|---|---|
| MASIMO CORP | MASI | 12.7% |
| TERNS PHARMACEUTICALS INC | TERN | 6.6% |
| SILICON LABORATORIES INC | SLAB | 4.1% |
| ARCELLX INC | ACLX | 4.0% |
| LIBERTY BROADBAND CORP | LBRDK | 3.9% |
| TRI POINTE GROUP INC. | TPH | 3.7% |
| UNIFIRST CORP MASS | UNF | 2.6% |
| APELLIS PHARMACEUTICALS INC | APLS | 1.6% |
| TWO HARBORS INVENTMENT CORPO | TWO | 1.1% |
| DAY ONE BIOPHARMACEUTICALS I | DAWNGBX | 1.1% |
| LIFEWAY FOODS INC | LWAY | 0.9% |
| VALARIS LTD | VAL | 0.7% |
Net Portfolio Value ChangeQ2 2026
- $0.3BPrior quarter
- $0.4BCurrent quarter
- +$0.0BNet delta
- +6.8%% change
Methodology & FAQ
How Slotnik Capital, LLC Quarterly Changes Are Computed
All deltas are sourced from sequential SEC Form 13F-HR filings for Slotnik Capital, LLC: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description, including how confidential treatment filings are handled, is documented in the Methodology.
What stocks did Slotnik Capital, LLC buy in Q2 2026?
In Q2 2026, Slotnik Capital, LLC initiated 14 new positions (TAYLOR MORRISON HOME CORP (TMHC), APOGEE THERAPEUTICS INC (APGE), GLOBALSTAR INC (GSAT), NUVALENT INC (NUVL), BIO-TECHNE CORP (TECH), ROKU INC (ROKU), BROWN-FORMAN CORP CL A (BF/A), ARCOSA INC (ACA), LIVERAMP HLDGS INC (RAMP), ARRAY DIGITAL INFRASTRUCTURE (AD), BEAZER HOMES USA INC (BZH), SYNAPTICS INC (SYNA), BIO RAD LABS INC (BIO), OLAPLEX HLDGS INC (OLPX)); bought more shares of KENVUE INC (KVUE), PENUMBRA INC (PEN), ATRIUM THERAPEUTICS INC (RNA), NORFOLK SOUTHN CORP (NSC).
What stocks did Slotnik Capital, LLC sell in Q2 2026?
In Q2 2026, Slotnik Capital, LLC fully sold 12 positions (MASIMO CORP (MASI), TERNS PHARMACEUTICALS INC (TERN), SILICON LABORATORIES INC (SLAB), ARCELLX INC (ACLX), LIBERTY BROADBAND CORP (LBRDK), TRI POINTE GROUP INC. (TPH), UNIFIRST CORP MASS (UNF), APELLIS PHARMACEUTICALS INC (APLS), TWO HARBORS INVENTMENT CORPO (TWO), DAY ONE BIOPHARMACEUTICALS I (DAWNGBX), LIFEWAY FOODS INC (LWAY), VALARIS LTD (VAL)); reduced holdings in MISSION PRODUCE INC (AVO), WEBSTER FINL CORP (WBS), CHART INDS INC (GTLS), LIBERTY BROADBAND CORP (LBRDA), WARNER BROS DISCOVERY INC (WBD).
Which positions did Slotnik Capital, LLC initiate in Q2 2026?
Slotnik Capital, LLC established 14 new positions in Q2 2026: TAYLOR MORRISON HOME CORP (TMHC, 10.7%), APOGEE THERAPEUTICS INC (APGE, 9.6%), GLOBALSTAR INC (GSAT, 7.9%), NUVALENT INC (NUVL, 7.2%), BIO-TECHNE CORP (TECH, 4.0%), ROKU INC (ROKU, 2.6%), BROWN-FORMAN CORP CL A (BF/A, 2.5%), ARCOSA INC (ACA, 1.8%), LIVERAMP HLDGS INC (RAMP, 1.6%), ARRAY DIGITAL INFRASTRUCTURE (AD, 1.3%), BEAZER HOMES USA INC (BZH, 1.2%), SYNAPTICS INC (SYNA, 0.6%), BIO RAD LABS INC (BIO, 0.6%), OLAPLEX HLDGS INC (OLPX, 0.6%).
Which existing positions saw the largest allocation increases for Slotnik Capital, LLC in Q2 2026?
Of 4 existing positions with share-count increases in Q2 2026, the largest were: KENVUE INC (KVUE, +4.3% weight, +89.6% shares), PENUMBRA INC (PEN, +1.8% weight, +31.7% shares), ATRIUM THERAPEUTICS INC (RNA, +0.2% weight, +31.3% shares), NORFOLK SOUTHN CORP (NSC, +0.3% weight, +17.6% shares).
Which positions did Slotnik Capital, LLC fully exit in Q2 2026?
Slotnik Capital, LLC fully exited 12 positions in Q2 2026: MASIMO CORP (MASI, last-reported weight 12.7%), TERNS PHARMACEUTICALS INC (TERN, last-reported weight 6.6%), SILICON LABORATORIES INC (SLAB, last-reported weight 4.1%), ARCELLX INC (ACLX, last-reported weight 4.0%), LIBERTY BROADBAND CORP (LBRDK, last-reported weight 3.9%), TRI POINTE GROUP INC. (TPH, last-reported weight 3.7%), UNIFIRST CORP MASS (UNF, last-reported weight 2.6%), APELLIS PHARMACEUTICALS INC (APLS, last-reported weight 1.6%), TWO HARBORS INVENTMENT CORPO (TWO, last-reported weight 1.1%), DAY ONE BIOPHARMACEUTICALS I (DAWNGBX, last-reported weight 1.1%), LIFEWAY FOODS INC (LWAY, last-reported weight 0.9%), VALARIS LTD (VAL, last-reported weight 0.7%).
Which existing positions saw the largest allocation reductions for Slotnik Capital, LLC in Q2 2026?
Of 5 existing positions with share-count reductions in Q2 2026, the largest were: MISSION PRODUCE INC (AVO, -1.8% weight, -45.1% shares), WEBSTER FINL CORP (WBS, -2.3% weight, -43.4% shares), CHART INDS INC (GTLS, -6.1% weight, -41.4% shares), LIBERTY BROADBAND CORP (LBRDA, -3.7% weight, -33.1% shares), WARNER BROS DISCOVERY INC (WBD, -1.2% weight, -18.4% shares).
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.